In Hong Kong this August, more than three thousand clinicians, engineers, investors, and policymakers gathered to confront one of medicine's oldest tensions: the distance between discovery and the patient who needs it. The 2026 Global Health Summit, co-hosted by New Frontier Group and the Hong Kong Investment Corporation, treated that distance not as inevitable but as a design problem — one that artificial intelligence, aligned capital, and cross-border regulatory clarity might finally solve. Hong Kong itself emerged as more than a host city; it was offered as a model for how a place can becom